Anticoagulation Management for Mechanical Heart Valves

Target INR Ranges

The American Heart Association recommends target INR ranges of 2.0-3.0 for mechanical aortic valves and 2.5-3.5 for mechanical mitral valves 1, 2, 3, 4, 5

The target INR ranges for different valve types are as follows:

Valve Type	INR Target Range
Aortic position mechanical valves (bileaflet and Medtronic Hall valves)	2.0-3.0
Mitral position mechanical valves	2.5-3.5
Aortic position mechanical valves with risk factors	2.5-3.5
Older-generation mechanical valves	2.5-3.5
Bioprosthetic valves	2.0-3.0 (for the first 3 months)

Patients with mechanical mitral valves have a higher thromboembolic risk than those with aortic valves 2
The American Heart Association recommends the addition of low-dose aspirin (75-100 mg daily) to warfarin therapy for all patients with mechanical valves to further reduce thromboembolic risk 1, 2, 4, 8
The American College of Cardiology and the American Heart Association recommend anticoagulation therapy for patients with mechanical heart valves to prevent valve thrombosis and systemic embolization 1, 3, 4, 5

Patient education should include consistent vitamin K intake in diet, medication compliance with a simplified regimen, recognition of bleeding signs and symptoms, and importance of regular INR monitoring 10
The American College of Cardiology recommends monitoring INR at least monthly, with the possibility of extending to a maximum of 4-6 weeks in carefully selected patients with consistently therapeutic INRs 11
The European Society of Cardiology recommends monitoring INR at least monthly once stable, and considering more frequent monitoring for patients with fluctuating INRs 10

The risk of major bleeding increases considerably when INR exceeds 4.5 and increases exponentially above an INR of 6.0, with high variability of INR being a strong independent predictor of reduced survival after valve replacement 10
For patients with an INR greater than 4, the European Society of Cardiology recommends temporarily holding warfarin dose and rechecking the INR in 24-48 hours, then adjusting the weekly dose by 10-15% when warfarin is restarted 10
For INR 5.0-9.0 without bleeding, hold warfarin and consider low-dose oral vitamin K (1-2 mg) if the patient is at high risk of bleeding, as recommended by the American Heart Association 10, 2
For INR > 9.0 without bleeding, hold warfarin, give oral vitamin K 2.5-5 mg, and recheck INR within 24 hours 10
For any INR with serious bleeding, immediate reversal of anticoagulation is required, using intravenous prothrombin complex concentrate or fresh frozen plasma, and intravenous vitamin K (5-10 mg), as recommended by the American College of Cardiology 10, 2

Older patients (≥75 years) typically require approximately 1 mg/day less warfarin than younger individuals to maintain comparable INR, and should start with lower doses due to increased bleeding risk 12
The American Heart Association warns against high-dose vitamin K in patients with mechanical valves as it may create a hypercoagulable condition 2, 7
The American Geriatrics Society suggests that elderly patients require smaller dose adjustments (5-10%) due to increased sensitivity to warfarin and higher bleeding risk 13